Am J Ind Med by Yiin, James H. et al.
A Study Update of Mortality in Workers at a Phosphate Fertilizer 
Production Facility
James H. Yiin, PhD1,*, Robert D. Daniels, PhD1, Travis L. Kubale, PhD1, Kevin L. Dunn, MS1, 
and Leslie T. Stayner, PhD2
1Division of Surveillance, Hazard Evaluations, and Field Studies, National Institute for 
Occupational Safety and Health, CDC, Cincinnati, Ohio
2Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at 
Chicago, Chicago, Illinois
Abstract
Objective—To evaluate the mortality experience among 3,199 workers employed 1951–1976 at a 
phosphate fertilizer production plant in central Florida with follow-up through2011.
Methods—Cause-specific standardized mortality ratios (SMRs) for the full cohort were 
calculated with the U.S. population as referent. Lung cancer and leukemia risks were further 
analyzed using conditional logistic regression.
Results—The mortality due to all-causes (SMR = 1.07, 95% confidence interval [CI] 1.02–1.13, 
observed deaths [n] = 1,473), all-cancers (SMR = 1.16, 95%CI 1.06–1.28, n = 431), and a priori 
outcomes of interests including lung cancer (SMR = 1.32, 95%CI = 1.13–1.53, n = 168) and 
leukemia (SMR = 1.74, 95%CI = 1.11–2.62, n = 23) were statistically significantly elevated. 
Regression modeling on employment duration or estimated radiation scores did not show 
exposure–response relation with lung cancer or leukemia mortality.
Conclusion—SMR results showed increased lung cancer and leukemia mortality in a full cohort 
of the phosphate fertilizer production facility. There was, however, no exposure–response relation 
observed among cases and matched controls.
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INTRODUCTION
The United States is the second leading manufacturer of phosphate-based fertilizers 
worldwide. Nearly all phosphate production occurs in the Florida peninsula, where the 
industry maintains the mineral rights to about 440,000 acres of Florida land and has a multi-
billion dollar capital investment in the state. Phosphate mining and processing can involve 
occupational exposures to a number of hazardous substances including uranium and radon 
daughters [Rutherford et al., 1995; BEIR VI, 1999], sulfuric and phosphoric acids, and acid 
mists [Hsu et al., 2007a]; other inorganic mists containing sulfate, fluoride, ammonium, and 
phosphate [Hsu et al., 2007b] and aerosols containing technically enhanced, naturally 
occurring radioactive material (TENORM) [Birky et al., 1998; Kim et al., 2006]. In 
particular, plant processes included the economic recovery of uranium for U.S. nuclear 
weapons production in the 1950s [Greek et al., 1957].
Studies have been conducted on workers employed in the Florida phosphate industry. 
Checkoway et al. [1985] studied a large phosphate worker cohort (n = 22,323) assembled 
from the employment records of 16 companies involving mining and chemical processing. 
With 10% confirmed deaths, they found a small excess of lung cancer mortality among 
phosphate workers when compared to U.S. rates, but not to local rates. Elevated emphysema 
mortality among White and workers of other races was also reported. These results, 
however, were statistically significant for White males only. A later study of the cohort was 
conducted adding 14 years of vital status follow-up and the workers known to be deceased 
increased to 21% [Checkoway et al., 1996]. This study conducted limited exposure–response 
analyses using job-based surrogates of exposure. The authors reported weak trends of lung 
cancer risk with alpha and gamma radiation among White males, and the overall conclusion 
was no large excesses of lung cancer mortality or other diseases related to workplace 
exposures.
Stayner et al. [1985] conducted a retrospective mortality study of 3,199 phosphate fertilizer 
production workers with follow-up through December 31, 1977. The study did not reveal an 
overall excess in cause-specific mortality in the population; however, a statistically 
significant excess of lung cancer among men of races other than White with greater than 10 
years of employment and follow-up (SMR = 4.11, P < 0.05) was observed. Sixty percent 
(3/5) of the lung cancer cases among workers of other races were first employed as clean-up 
men, a job that 59% of this subpopulation had held. By comparison, only 1% of Whites had 
held this position, involving cleaning the phosphoric acid reaction vessel, which had 
potential for exposures to uranium and radon daughters. Although suggestive, these results 
were tempered by the fact that only 5.5% of the study population was known to be deceased 
at time of follow-up and there were few lung cancer cases (n = 10) observed. Moreover, the 
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study had limited work history and exposure information; thus, exposure response was not 
examined.
Block et al. [1988] found significant excesses of lung cancer (SMR = 1.62) and emphysema 
(SMR = 2.19) among White men (n = 2,607) employed by a Florida phosphate company 
between 1950 and 1979. Also observed was an increasing trend in lung cancer risk with 
increasing employment duration among workers accruing 20 years or more since first 
exposure. Like the preceding studies, only a small portion (14%) of the study population was 
deceased at time of follow-up [Block et al., 1988].
The current study reexamined the cause-specific mortality patterns among the cohort of 
phosphate fertilizer production workers originally studied by Stayner et al. [1985] with more 
work history information collected in 2007 and an additional 34 years of vital status follow-
up through December 31, 2011. Additionally, because exposure to radiation has been linked 
to certain cancers [IARC Monograph Volume 100D, 2012], the possible connection between 
radiation exposures among phosphate fertilizer production workers and excesses in cancers, 
specifically lung cancer and leukemia, was also evaluated using a newly developed exposure 
assessment for radiation in a nested case–control study design. Potential confounding by co-
exposures to acid mists and solvents was also considered in these analyses.
MATERIALS AND METHODS
Cohort Definition
A detailed description of the cohort is provided in the previous study [Stayner et al., 1985]. 
Briefly, the cohort included 3,199 workers who were employed at least one day from 1951 
to 1976 at a now defunct phosphate-fertilizer production facility in central Florida. 
Demographic information including name, social security number, birth date and race as 
well as occupational histories including dates employed and job titles were obtained from 
personnel records. For race, White was coded as “White,” whereas all other races such as 
African-American, Asian, and Other were coded as “Other Races.” Vital status was updated 
through 2011 using the National Death Index (NDI), Social Security Administration (SSA) 
mortality database, and other available databases such as LexisNexis. Underlying cause of 
death (UCOD) information was coded according to the International Classification of 
Diseases (ICD) revision in effect at the time of death. The loss of follow-up was 2% (n = 
63).
Outcomes of Interest
Cancer cases were defined by UCOD. Respiratory cancers and non-malignant lung disease 
(e.g., emphysema) were a priori outcomes of interest because of elevations observed in 
previous studies of this cohort [Stayner et al., 1985] and other phosphate worker populations 
[Checkoway et al., 1985; Block et al., 1988; Checkoway et al., 1996]. Exposure to strong 
inorganic acid mists containing sulfuric acid has been linked to excess lung cancer and 
laryngeal cancer [Steenland et al., 1988; Steenland and Beaumont, 1989; Steenland, 1997]. 
Leukemia mortality was also of interest because of its known association with ionizing 
radiation and for having few other known risk factors. A potential exception is some solvents 
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that are known or suspected leukemogens [Schottenfeld and Fraumeni, 2006]. Although 
there was no evidence of widespread use in plant processes, these solvents may have been 
used by some workers in the course of their employment at the plant. Common solvents 
include laboratory reagents, equipment degreasers, cutting fluids, and paint thinners used by 
laboratory workers, mechanics, machinists, carpenters, and painters.
Exposure Assessment
Low-level exposure to ionizing radiation from radio-nuclides in the uranium decay series 
was likely for phosphate workers throughout their careers, particularly during uranium 
extraction operations in early years because of direct involvement with uranium compounds 
during recovery processes. Information gathered from routine plant operations suggested 
that the average annual total effective dose equivalent (TEDE) resulting from occupational 
TENORM exposure is below 1.0 mSv. The TEDE primarily stems from inhalation of 
TENORM suspended in airborne dusts and from short-lived radon decay products. More 
detailed work history information was collected in 2007. An extensive search for 
information has not revealed a means to identify uranium extraction workers (other than 
dates of operation), radiation dosimetry, or survey records related to extraction operations. In 
the absence of these data, we estimated radiation by job titles with exposure potential. 
Similarly, job titles were also used to develop exposure estimates for solvents and acid mists.
The exposure assessment was conducted by an industrial hygienist who was blinded to case 
status. Direct information on individual worker occupational exposures was not available; 
therefore, surrogates for exposure were developed from existing employment histories and 
process knowledge. Primary agents of interest were ionizing radiation and potential 
confounders such as acid mist and solvents. Job exposure matrices (JEMs) were developed 
to evaluate combinations of work duration, job titles, and department assignments. This 
information was used to calculate exposure “scores” for each work interval. For each 
worker, a score for the ith work interval was calculated as the product of exposure level (Li), 
interval duration (Di) in days, supervisory status (Si), and a calendar period weighting factor 
to account for improvements in protective standards and engineering controls over time (Ti). 
The value for Li was selected from an ordinal set of values (i.e., Li 0, 0.1, 0.5, or 1) 
representing a gradient in exposure intensity based on job assignment and the exposure 
agent of interest. The value for Si was assigned 0.5 for supervisory and 1 for non-
supervisory production workers to indicate a general decrease in exposure potential among 
supervisory personnel. The selection of a value for Ti was consistent with the time-
dependent weighting scheme used by Henn et al. [2007]. For each worker and exposure 
surrogate, cumulative exposure scores were calculated by summing interval values from age 
at first exposure to attained age minus any imposed exposure lag period.
Statistical Analysis
External comparisons of mortality rates were made using the NIOSH Life Table Analysis 
System (LTAS.NET). Observed deaths were classified into 1 of 92 cause-of-death categories 
[Robinson et al., 2006]. The expected numbers of deaths were estimated for all-deaths 
combined, all-cancer deaths combined, and each cause-specific death category as the 
product of U.S. population death rates and the person years at risk of dying (PYARS) in 
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strata of race (White, all others), sex, and 5-year periods of age and calendar time 
[Schubauer-Berigan et al., 2011]. Death rates were available beginning in 1940 for most 
cancers of interest and beginning in 1960 for non-Hodgkin’s lymphoma and multiple 
myeloma. Observed deaths and PYARS were accumulated from the later of the date of first 
hire or the year of rate availability through the end of the study (December 31, 2011), date 
lost to follow-up, or the date of death, whichever occurred first.
Numbers of deaths observed for each cause were divided by the expected number of deaths 
to calculate standardized mortality ratios (SMRs). SMRs were also calculated by duration of 
employment categories (0–<1, 1–0<10, 10–<20, and 20+ years) and length of follow-up/
time since first employment (TSFE) categories (0–<20, 20–<30, and 30+ years) for lung 
cancer mortality among males and leukemia mortality among White males.
LTAS.NET was used to conduct stratified internal comparisons of the relation between lung 
cancer and leukemia mortality and employment duration. Standardized rate ratios (SRRs) 
were calculated for strata of employment duration whereby the SRR is the ratio of the 
directly standardized stratum rate to the rate in the lowest exposed stratum (0–<1 years). As 
an internally adjusted comparison of rates, the SRR analysis is better suited for analysis 
involving across strata comparisons.
Stratified SMR and SRR analyses by duration of employment and TSFE were conducted for 
lung cancer among males and leukemia among White males. The analyses were not 
performed for females (3 lung cancer and 2 leukemia deaths) or leukemia among males of 
other races (1 death) as there were few deaths. Two-sided 95% confidence intervals (CIs) on 
the SMRs and SRRs and 2-sided tests of linear trend SRRs were conducted as described 
elsewhere [Steenland et al., 1990].
Nested Case–Control Modeling Analysis
For the nested case–control design, conditional logistic regression analyses were conducted 
to examine the relation between estimated occupational exposures to radiation and select 
outcomes with adjustment for potential confounders of other occupational exposures (e.g. 
acid mist in lung cancer and solvent in leukemia mortality). Multicollinearity among 
exposure metrics was examined by regression diagnostics [Davis et al., 1986]. An additional 
criterion of working 30 days or more was applied in selecting cases and controls. Risk sets 
were defined for each case of interest to include all other cohort members who were under 
observation and who lived to an age equal to or greater than the age of the case at death. A 
ratio of case to controls of 1:5 for lung cancer and 1:l0 for leukemia was used [Bertke et al., 
2013], with all exposures received by the controls truncated at the age attained of the case. 
Model estimates included two-sided 95% profile likelihood confidence intervals. All models 
were also adjusted for sex, race, and birth cohort. Birth cohort effects were estimated using 
continuous variables constructed from terms calculated by restricted cubic splines with three 
knots at the 10th, 50th, and 90th centiles of birth year [Harrell, 2001]. Alternative models 
with duration or estimated exposure scores with lags of 10 years for lung cancer and 2 years 
for leukemia were also evaluated. All modeling was conducted using SAS Software, Version 
9.1.3 [SAS Institute, Inc., 2007].
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There were 3,173 workers with complete data available within the study period for analyses. 
The cohort is predominantly male (93%) and White (78%). Over half of the workers were 
short-term with less than 1 year of employment duration (n = 1,711). Compared with only 
176 (5.5%) workers known to be deceased in the original study, the current study observed 
1,473 deaths (46%) with over 3 decades of extended follow-up (Table I).
Among the 431 cancer deaths, 168 (including 124 White males, 3 White females, and 41 
males of other races) died of lung cancer and 23 of leukemia (20 White males, 2 White 
females, and 1 male of other races). Twenty-nine lung cancer cases had employment 
duration less than 30 days, and thus were not included in the nested case–control analyses 
(Table II). All of the leukemia cases met the criteria of being employed 30 or more days and 
were included in the regression analyses.
SMR and SRR Analyses
A total of 124,363 person-years were accumulated in this cohort. There was a slight but 
statistically significant elevation in the all-cause mortality compared to the U.S. population. 
The mortality from all cancers was also statistically significantly elevated. Significant 
elevations were observed for the a priori outcomes of interests of lung cancer and leukemia 
as well as other outcomes such as other mental disorders and chronic obstructive pulmonary 
disease (COPD) (Table III). SMR results excluding workers with less than 30 days of 
employment were similar (results not shown).
When the full cohort was compared to the Florida population, the mortality from all causes 
(SMR = 1.09, 95%CI 1.03–1.14), all cancers (SMR = 1.17, 95%CI 1.06–1.29), lung cancer 
(SMR = 1.28, 95%CI 1.10–1.49), leukemia (SMR = 1.82, 95%CI 1.15–2.73), other mental 
disorders (SMR = 2.05, 95%CI 1.31–3.05), and COPD (SMR = 1.65, 95%C.I. 1.32–2.03) 
remained significantly elevated.
SMR results for White males were very similar to those for the entire cohort. It is not 
surprising that the results for White males resembled the overall cohort as they made up 
about 78% of the cohort. For males of other races, elevated SMRs were observed for all 
cancers (SMR = 1.25, 95%CI 1.03–1.51, number of deaths [n] = 109), multiple myeloma 
(SMR = 3.01, 95%CI 1.10–6.55, n = 6), and diabetes mellitus (SMR = 1.87, 95%CI 1.14–
2.89, n = 20). The all-cause (SMR = 1.08, 95%CI 0.98–1.20, n = 386) and lung cancer 
(SMR = 1.37, 95%CI 0.98–1.86, n = 41) mortality was also elevated among males of other 
races. For White females, there was deficit in all-cause (SMR = 0.87, 95%CI 0.67–1.11, n = 
65) and all-cancer (SMR = 0.57, 95%CI 0.30–0.97, n = 13) mortality, but an increase in 
other heart disease mortality (SMR = 2.32, 95%CI 1.00–4.58, n = 8). The SMR analysis was 
not reported for females of other races as there were less than five observed deaths.
Table IV shows stratified SMRs and 95%CIs by duration of employment and TSFE for lung 
cancer among males. Excess in lung cancer mortality was observed with 20–30 years of 
follow-up among White males with less than 1 year of employment and males of other races 
with 20+ years of employment. The leukemia SMRs among White males were elevated but 
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not statistically significant due to small numbers of deaths and resulting wide confidence 
intervals in all duration of employment and TSFE strata. There was no clear trend in lung 
cancer or leukemia mortality with increased duration of employment.
SRR analyses among male workers also failed to show an apparent increasing trend in 
mortality risk with increased duration of employment, with or without a lag of 10 years for 
lung cancer or 2 years for leukemia. As shown in Table V, SRR without a lag peaked at 
employment duration 10–<20 years, but dropped at the longest duration (20+ years). The 
overall results with a lag (not shown) followed the same pattern.
Nested Case–Control Modeling Analysis
In the nested case–control study analysis, the mean duration of employment without a lag 
was 6.8 years for lung cancer cases (n = 139) and 6.9 years for their matched controls (n = 
695) as shown in Table VI. There was a slight difference in mean duration (5.9 for lung 
cancer cases vs. 6.2 years for controls) when a lag of 10 years was considered. Leukemia 
cases (n = 23) had longer mean duration of employment than the controls (n = 230) (7.0 vs. 
5.6 years with or without a 2-year lag). There were slightly higher estimated mean radiation 
exposure scores from JEM among the lung cancer cases (2.3–2.5) than their controls (2.2–
2.3) with or without a lag. The estimated mean exposure to radiation was also higher in 
leukemia cases (2.4) than in the controls (2.0).
There was little evidence of an association between lung cancer or leukemia mortality and 
employment duration or radiation exposure scores, with or without a lag, in the conditional 
regression analyses with adjustment for gender, race, birth cohort, and potential confounder 
(Table VI). Multicollinearity was not evident among estimated radiation, acid mist, and 
solvent scores. The relative risks per year of employment were 0.98 for lung cancer and 1.03 
for leukemia, with or without a lag. With estimated radiation exposure scores, the relative 
risks were 0.98 for lung cancer and 1.08–1.09 for leukemia, with or without a lag. Based on 
the log-likelihood scores and changes in radiation parameter estimates, the results showed 
birth cohort effects on both outcomes, and some impact of gender on lung cancer as well as 
race and solvent on leukemia. The model fit did not improve when an interaction of the 
estimated radiation score and hire indicator (prior or on/after 1960) was added.
DISCUSSION
The analyses presented here describe the mortality experience of a previously studied cohort 
of phosphate fertilizer production workers, with follow-up extended over 3 decades. The 
previous study did not find significant elevations in cause-specific mortality in the cohort, 
likely due to a relatively young population and shorter follow-up. With extended follow-up, 
higher mortality rates from all-causes, all cancers, lung cancer, leukemia, and some 
nonmalignant diseases (e.g., other mental disorders and COPD) were now apparent among 
these workers compared to the U.S. population. The new findings were likely attributable to 
increased statistical power from prolonged follow-up and aging of the population. 
Additionally, the improved ascertainment resulted in a reduction in the number of deaths of 
unknown cause (20 in 1,473 or 1.4%, vs. 16 in 155 or 10% in the previous study). Analyses 
by gender-race groups also showed differences in mortality by race among males. White 
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males had higher leukemia risk but lower multiple myeloma and diabetes mellitus risk than 
males of other races. Leukemia mortality was statistically significantly increased among 
2,282 White males (SMR = 1.96, 95%CI 1.20–3.03, n = 20) but non-significantly decreased 
among 680 males of other races (SMR = 0.44, 95%CI 0.01–2.48, n = 1). On the contrary, 
multiple myeloma mortality was statistically significantly increased among males of other 
races (SMR = 3.01, 95%CI 1.10–6.55, n = 6) but not among White males (SMR = 0.90, 
95%CI 0.25–2.31, n = 4). The differences were not apparent among females possibly 
because there were far fewer female workers in the cohort.
The previous study reported an excess of lung cancer mortality (SMR = 4.11, one-tail P < 
0.05, n = 3) among males of other races with greater than 10 years of employment and 
follow-up. The increase, although not statistically significant, persisted in the current study 
(SMR = 1.36, 95%CI 0.55–2.79, n = 7) with 20+ years of employment and follow-up. 
Further dividing the follow-up to 20–<30 and 30+ years resulted in significant increases 
among male workers of other races with 20+ years of employment and 20–30 years of 
follow-up (SMR = 4.59, P < 0.05) as well as White males with the least amount of 
employment (0–1 years) and the same length of follow-up (SMR = 2.66, P < 0.01) (Table 
IV). Further examination with SRR analyses in Table V did not reveal any trend of increased 
mortality with increased employment duration in either race group.
It is known that a greater proportion (59%) of males of other races (vs. 1% of Whites) 
worked as clean-up men who were assigned to clean the phosphoric acid reaction vessel. 
Crushed phosphate ore was mixed with sulfuric acid in these vessels to produce dicalcium 
phosphate and gypsum as a byproduct, and once a year before 1975 workers entered the 
vessel to chip away gypsum deposits from the agitator [Stayner et al., 1985]. This was 
thought to be the primary exposure to potential respiratory carcinogens that included 
chromium, arsenic, uranium, and radon daughters, and thus a potentially greater risk existed 
among males of other races. Our results in stratified SMR analyses showed that males of 
other races still had higher lung cancer mortality risk, especially those with 20+ years of 
employment and 20–<30 years of follow-up. Lung cancer mortality, however, did not differ 
by race (SMR = 1.35, 95%CI 1.13–1.61, n = 124 among White males vs. SMR = 1.37, 
95%CI 0.98–1.86, n = 41, among males of other races).
The excess in other mental disorders (SMR = 1.83, P < 0.01) was an unexpected finding. 
Among the 24 deaths in this category, the average age at death was 80, two-thirds (n = 16) 
were reported from the state of Florida, and 22 in recent years (1999–2011 using ICD-10). 
The SMR increased to 2.05 (P < 0.01) when Florida rates were used as the reference. A 
possible explanation is that there may be more reported cases in Florida, but there are also 
more healthy people of older age groups in the state that result in lowered age-adjusted 
mortality rates. Another possibility is diagnostic bias due to systematical misclassification 
by medical examiners or care providers unfamiliar with patients before death [Silverstein et 
al., 1988].
The study has a number of important limitations. First, direct information on individual 
exposures was not available. Instead, exposure–response modeling was conducted using 
surrogates of exposure derived from employment information. Although these methods are 
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common to worker studies, it is difficult to gauge their validity in the absence of direct 
measurement data. Our use of relatively crude surrogates increased the potential for 
misspecification of worker exposures that would likely attenuate estimated risk. Second, 
information on environmental and other occupational exposures was not available. Over half 
(54%) of the study population was employed less than 1 year; therefore, significant 
contributions to overall risk from exposures elsewhere are likely. Third, information on 
important lifestyle factors, such as tobacco use, was also lacking. In particular, lung cancer 
is strongly associated with smoking behavior; therefore, lung cancer risk estimates are 
largely uncertain without smoking information. It is noteworthy that mortality from 
cardiovascular diseases, which is also associated with smoking, was not elevated in this 
cohort suggesting that confounding by smoking is less likely. Finally, although some 
estimates were relatively precise, only modest associations were observed; therefore, results 
should be cautiously interpreted because small effects are more prone to potential biases.
This evaluation provided adequate follow-up to examine mortality from cancers with long 
latency. At the time of the initial analysis, 5.5% of the cohort was deceased, whereas in this 
updated analysis, 46% were deceased. This extended follow-up revealed modest, but 
statistically significant excess mortality for a number of outcomes of a priori interest. There 
is not, however, sufficient evidence to determine a causal association between any outcome 
and occupational exposure based on the limited information available in this cohort.
CONCLUSION
The cohort of 3,173 phosphate production workers employed between 1951 and 1976 with 
follow-up through 2011 showed statistically significantly elevated mortality in all-cause and 
all-cancer, lung cancer, and leukemia, when compared with the U.S. population. Neither 
stratified SMR analysis nor internal comparison with SRR analysis showed a trend of 
increasing mortality with increased employment duration. Conditional logistic regression 
analyses with lung cancer and leukemia cases and selected controls also failed to establish a 
statistically significant exposure–response relation with employment duration or estimated 
radiation exposure scores. Further studies in plants with similar exposures or with more 
information on environmental and lifestyle factors are needed to clarify the exposure–
response relation.
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TABLE I
Demographics of Phosphate Workers Employed 1951–1976 With Follow-Up Through 12/31/2011
Characteristics n (%)/mean (SD)
Sex
 Male 2,962 (93%)
 Female 211 (7%)
Race
 White 2,484 (78%)
 Other races 689 (22%)
Age at hire
 <30 2,186 (69%)
 30–<45 875 (28%)
 45–<60 110 (3%)
 60+ 2 (0%)
Mean age at hire (years) 27.3 (8.0)
Year of hire
 <1955 540 (17%)
 1955–1959 617 (19%)
 1960–1964 420 (13%)
 1964–1969 750 (24%)
 1970+ 846 (27%)
Duration of employment (years)
 0–<1 1,711 (54%)
 1–<10 939 (30%)
 10–<20 284 (9%)
 20+ 239 (8%)
Mean length of employment (years) 4.6 (8.1)
Mean age at last follow-up (years) 66.5 (12.6)
Vital status (as of 12/31/2011)
 Alive 1,700 (54%)
 Deceased 1,473 (46%)
SD, standard deviation.
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TABLE II
Workers, Deceased, and Lung Cancer and Leukemia Cases Among Workers by Gender and Race
Full cohort Workers with 30+ days of employment
Race/gender Total Dead (%) Lung Leukemia Total Dead (%) Lung Leukemia
Male—White 2,282 1,020 (45) 124 20 1,949 871 (45) 107 20
Male—all others 680 386 (57) 41 1 543 301 (55) 29 1
Female—White 202 65 (32) 3 2 183 60 (33) 3 2
Female—all others 9 2 (22) 0 0 8 2 (25) 0 0
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TABLE III
Selected Mortality Among Phosphate Workers Employed 1951–1976 With Follow-Up Through 12/31/2011
Underlying cause of death Observed SMR 95%CI
All causes 1,473 1.07* 1.02–1.13
Tuberculosis 2 0.71 0.09–2.55
All cancers 431 1.16** 1.06–1.28
MN buccal cavity and pharynx 6 0.68 0.25–1.48
MN tongue 1 0.50 0.01–2.77
MN other parts of buccal cavity 2 0.96 0.12–3.47
MN pharynx 3 0.64 0.13–1.88
MN digestive organs and peritoneum 84 0.91 0.73–1.13
MN esophagus 13 0.99 0.53–1.70
MN stomach 10 0.91 0.44–1.68
MN intestine except rectum 25 0.86 0.55–1.26
MN rectum 2 0.32 0.04–1.14
MN biliary, liver, gall bladder 14 1.16 0.64–1.95
MN pancreas 19 0.98 0.59–1.53
MN respiratory system 173 1.30** 1.11–1.51
MN larynx 5 1.08 0.35–2.52
MN trachea, bronchus, and lung 168 1.32** 1.13–1.53
MN breast 3 0.64 0.13–1.86
MN male genital organs 38 1.34 0.95–1.84
MN prostate 34 1.24 0.86–1.74
MN other male genital organs 4 3.93* 1.07–10.1
MN urinary organs 22 1.24 0.78–1.88
MN kidney 12 1.28 0.66–2.23
MN bladder and other urinary organs 10 1.20 0.57–2.20
MN other and unspecified sites 58 1.21 0.92–1.56
MN skin 13 1.69 0.90–2.89
Mesothelioma 1 0.90 0.02–5.00
MN brain and other nervous system 9 0.97 0.44–1.83
MN connective tissue 2 0.96 0.12–3.45
MN lymphatic and hematopoietic tissue 47 1.34 0.98–1.78
Non–Hodgkin's lymphoma 12 0.90 0.47–1.58
Hodgkin's disease 2 1.13 0.14-4.09
Leukemia 23 1.74* 1.11-2.62
Multiple myeloma 10 1.47 0.70-2.70
Diabetes mellitus 39 1.09 0.77-1.48
Diseases of blood and blood-forming organs 6 1.08 0.40–2.34
Mental, psychoneurotic, and personality disorders 30 1.35 0.91–1.92
Alcoholism 6 0.65 0.24–1.42
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Underlying cause of death Observed SMR 95%CI
Other mental disorders 24 1.83** 1.18–2.73
Disorders of nervous system and sense organs 33 1.07 0.74–1.51
Multiple sclerosis 1 0.64 0.02–3.58
Other nervous system diseases 32 1.10 0.75–1.55
Diseases of the heart 402 0.99 0.89–1.09
Rheumatic heart disease 1 0.24 0.01–1.33
Ischemic heart disease 312 0.98 0.88–1.10
Chronic disease of endocardium 8 1.29 0.56–2.53
Hypertension with heart disease 22 1.28 0.80–1.93
Other heart diseases 59 0.95 0.72–1.23
Other diseases of the circulatory system 95 0.92 0.74–1.12
Hypertension without heart disease 11 1.33 0.66–2.38
Cerebrovascular disease 64 0.97 0.74–1.23
Diseases of arteries, veins, pulmonary circulation 20 0.69 0.42–1.07
Diseases of the respiratory system 123 1.16 0.96–1.38
Pneumonia 21 0.74 0.46–1.13
Chronic obstructive pulmonary disease 87 1.54** 1.23–1.90
Asthma 3 1.38 0.28–4.03
Pneumoconiosis and other respiratory diseases 12 0.66 0.34–1.15
Diseases of the digestive system 71 1.14 0.89–1.43
Diseases of stomach and duodenum 3 0.72 0.15–2.11
Hernia and intestinal obstruction 1 0.37 0.01–2.06
Cirrhosis and other chronic liver diseases 34 1.04 0.72–1.46
Other diseases of digestive system 33 1.44 0.99–2.02
Diseases of the genitourinary system 16 0.65 0.37–1.05
Acute glomerulonephritis and renal failure 1 0.37 0.01–2.04
Chronic and unspecified nephritis and renal failure 8 0.54 0.23–1.06
Kidney infection 1 1.38 0.03–7.66
Other diseases of male genital organs 1 4.27 0.11–23.8
Other genitourinary diseases 5 0.90 0.29–2.11
Diseases of skin and subcutaneous tissue 2 1.35 0.16–4.87
Diseases of musculoskeletal system and connective tissue 2 0.51 0.06–1.85
Symptoms and ill-defined conditions 14 0.85 0.47–1.43
Accidents 88 1.05 0.84–1.29
Transportation accidents 50 1.19 0.89–1.57
Accidental poisoning 8 1.30 0.56–2.56
Accidental falls 4 0.42 0.11–1.07
Other accidents 25 1.01 0.65–1.49
Medical complications and misadventure 1 0.57 0.01–3.17
Violence 55 1.13 0.85–1.47
Suicide 31 1.19 0.81–1.68
Homicide 24 1.07 0.68–1.59
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Underlying cause of death Observed SMR 95%CI
Other causesa 41 0.90 0.64–1.22
SMR, standardized mortality ratio; CI, confidence intervals; MN, malignant neoplasm.
a
Excluding 20 deaths with missing or unknown cause.
*
Two-sided P < 0.05.
**
Two-sided P < 0.01.
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TABLE V
Lung Cancer and Leukemia SRRs (95%CI) by Employment Duration and Time Since First Employment 
(TSFE) Among Males
Employment duration (years)
TSFE 0–<1 1–<10 10–<20 20+
Years n Baseline n SRR (95%CI) n SRR (95%CI) n SRR (95%CI) Trend slope, P-valuea
Lung cancer—all races
 0–<20 4 1.0 6 1.74 (0.47, 6.41) 3 1.19 (0.26, 5.43) – NR
 20–<30 26 1.0 9 0.48 (0.21, 1.12) 7 1.03 (0.36, 2.93) 9 0.85 (0.33, 2.18) 1.31 × 10−5, 0.78
 30+ 50 1.0 32 0.89 (0.57, 1.40) 11 1.02 (0.51, 2.03) 8 0.41 (0.19, 0.89) −6.59 × 10−5, <0.01
 Total 80 1.0 47 0.81 (0.56, 1.18) 21 1.02 (0.61, 1.70) 17 0.76 (0.43, 1.35) −9.21 × 10−6, 0.35
Lung cancer—White
 0–<20 3 1.0 5 1.90 (0.42, 8.56) 2 1.14 (0.18, 7.12) – NR
 20–<30 21 1.0 9 0.47 (0.19, 1.14) 4 0.49 (0.13, 1.82) 4 0.41 (0.13, 1.32) −2.50 × 10−5, 0.37
 30+ 35 1.0 26 0.94 (0.56, 1.58) 9 1.07 (0.50, 2.31) 6 0.50 (0.20, 1.24) −5.26 × 10−5, <0.01
 Total 59 1.0 40 0.83 (0.55, 1.25) 15 0.86 (0.47, 1.58) 10 0.60 (0.29, 1.25) −1.83 × 10−5, <0.01
Lung cancer—other races
 0–<20 1 1.0 1 9.11 (0.57, 146) 1 1.54 (0.10, 24.7) – NR
 20–<30 5 1.0 0 0.00 (NR) 3 5.72 (1.15, 28.4) 5 2.00 (0.55, 7.22) NR
 30+ 15 1.0 6 0.85 (0.32, 2.25) 2 0.91 (0.20, 4.09) 2 0.30 (0.07, 1.40) −9.50 × 10−5, <0.01
 Total 21 1.0 7 1.02 (0.39, 2.71) 6 2.38 (0.77, 7.37) 7 1.18 (0.44, 3.15) 1.43 × 10−5, 0.51
Leukemia—White
 Total 8 1.0 7 0.94 (0.33, 2.68) 3 1.09 (0.27, 4.33) 2 0.79 (0.16, 3.92) −1.20 × 10−6, 0.22
SRRs, standardized rate ratios; CI, confidence intervals; NR, not reported due to cells with zero deaths.
a
Trend slopes with Wald-based two-sided P-values (significance level of 0.05) for the change in SRRs with increasing duration.
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TABLE VI
Summary Statistics and Model Results of Employment Duration and Radiation Exposure Scores
Cases Controls Rate ratioa
N Mean (SD) Range N Mean (SD) Range (95%CI)
Lung cancer
 Duration (years)
  No lag 139 6.8 (9.0) 0.09–33.9 695 6.9 (9.4) 0.09–43.0 0.98 (0.96–1.01)
  10-year lag 139 5.9 (7.9) 0–31.2 695 6.2 (8.9) 0–43.0 0.98 (0.95–1.01)
 Radiation (score)
  No lag 139 2.5 (3.7) 0–16.5 695 2.3 (4.0) 0–21.2 0.98 (0.93–1.04)
  10-year lag 139 2.3 (3.3) 0–14.9 695 2.2 (3.8) 0–19.7 0.98 (0.92–1.04)
Leukemia
 Duration (years)
  No lag 23 7.0 (9.5) 0.09–32.8 230 5.6 (8.2) 0.09–39.2 1.03 (0.96–1.09)
  2-year lag 23 7.0 (9.5) 0.09–32.8 230 5.6 (8.2) 0–39.2 1.03 (0.96–1.10)
 Radiation (score)
  No lag 23 2.4 (3.3) 0–12.3 230 2.0 (3.4) 0–15.3 1.08 (0.90–1.28)
  2-year lag 23 2.4 (3.3) 0–12.3 230 2.0 (3.4) 0–15.3 1.09 (0.91–1.29)
SD, standard deviation; CI, confidence intervals.
a
Rate ratio for one unit of exposure with adjustment for sex, race, birth cohort, and potential confounder.
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